Literature DB >> 11483737

Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes.

M Canki1, J N Thai, W Chao, A Ghorpade, M J Potash, D J Volsky.   

Abstract

Human astrocytes can be infected with human immunodeficiency virus type 1 (HIV-1) in vitro and in vivo, but, in contrast to T lymphocytes and macrophages, virus expression is inefficient. To investigate the HIV-1 life cycle in human fetal astrocytes, we infected cells with HIV-1 pseudotyped with envelope glycoproteins of either amphotropic murine leukemia virus or vesicular stomatitis virus. Infection by both pseudotypes was productive and long lasting and reached a peak of 68% infected cells and 1.7 microg of viral p24 per ml of culture supernatant 7 days after virus inoculation and then continued with gradually declining levels of virus expression through 7 weeks of follow-up. This contrasted with less than 0.1% HIV-1 antigen-positive cells and 400 pg of extracellular p24 per ml at the peak of astrocyte infection with native HIV-1. Cell viability and growth kinetics were similar in infected and control cells. Northern blot analysis revealed the presence of major HIV-1 RNA species of 9, 4, and 2 kb in astrocytes exposed to pseudotyped (but not wild-type) HIV-1 at 2, 14, and 28 days after infection. Consistent with productive infection, the 9- and 4-kb viral transcripts in astrocytes infected by pseudotyped HIV-1 were as abundant as the 2-kb mRNA during 4 weeks of follow-up, and both structural and regulatory viral proteins were detected in infected cells by immunoblotting or cell staining. The progeny virus released by these cells was infectious. These results indicate that the major barrier to HIV-1 infection of primary astrocytes is at virus entry and that astrocytes have no intrinsic intracellular restriction to efficient HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483737      PMCID: PMC115036          DOI: 10.1128/jvi.75.17.7925-7933.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis.

Authors:  R Brack-Werner
Journal:  AIDS       Date:  1999-01-14       Impact factor: 4.177

2.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.

Authors:  K Takahashi; S L Wesselingh; D E Griffin; J C McArthur; R T Johnson; J D Glass
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome.

Authors:  S A Lipton; H E Gendelman
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

5.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

7.  Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

Authors:  F Sabri; E Tresoldi; M Di Stefano; S Polo; M C Monaco; A Verani; J R Fiore; P Lusso; E Major; F Chiodi; G Scarlatti
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

8.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

Authors:  G J Nuovo; F Gallery; P MacConnell; A Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

9.  Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.

Authors:  L Zhang; T He; Y Huang; Z Chen; Y Guo; S Wu; K J Kunstman; R C Brown; J P Phair; A U Neumann; D D Ho; S M Wolinsky
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

View more
  60 in total

1.  Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells.

Authors:  Amitabha Sengupta; Sarah M Mense; Changgui Lan; Mei Zhou; Rory E Mauro; Lisa Kellerman; Galina Bentsman; David J Volsky; Elan D Louis; Joseph H Graziano; Li Zhang
Journal:  Neurotoxicology       Date:  2006-11-07       Impact factor: 4.294

2.  Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.

Authors:  Ashok Chauhan
Journal:  Microbes Infect       Date:  2015-06-02       Impact factor: 2.700

3.  A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Authors:  Mary Jane Potash; Wei Chao; Galina Bentsman; Nicolae Paris; Manisha Saini; Jadwiga Nitkiewicz; Paula Belem; Leroy Sharer; Andrew I Brooks; David J Volsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

4.  Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.

Authors:  Chi L Ong; Janine C Thorpe; Paul R Gorry; Sylvie Bannwarth; Anthony Jaworowski; Jane L Howard; Sean Chung; Shahan Campbell; Helen S Christensen; Guerline Clerzius; Andrew J Mouland; Anne Gatignol; Damian F J Purcell
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

6.  Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection.

Authors:  David Y-W Lee; Xudong Lin; Elena E Paskaleva; Yanze Liu; Shadakshara S Puttamadappa; Carol Thornber; James R Drake; Maja Habulin; Alexander Shekhtman; Mario Canki
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

Review 7.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

8.  A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia.

Authors:  Qiusheng Si; Melissa Cosenza; Mee-Ohk Kim; Meng-Liang Zhao; Michael Brownlee; Harris Goldstein; Sunhee Lee
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

9.  Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2).

Authors:  Zao-zhong Su; Magdalena Leszczyniecka; Dong-chul Kang; Devanand Sarkar; Wei Chao; David J Volsky; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

10.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.